These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

327 related items for PubMed ID: 9614217

  • 21. M1 receptor agonist activity is not a requirement for muscarinic antinociception.
    Sheardown MJ, Shannon HE, Swedberg MD, Suzdak PD, Bymaster FP, Olesen PH, Mitch CH, Ward JS, Sauerberg P.
    J Pharmacol Exp Ther; 1997 May; 281(2):868-75. PubMed ID: 9152396
    [Abstract] [Full Text] [Related]

  • 22. Application of transfected cell lines in studies of functional receptor subtype selectivity of muscarinic agonists.
    Wang SZ, el-Fakahany EE.
    J Pharmacol Exp Ther; 1993 Jul; 266(1):237-43. PubMed ID: 7687290
    [Abstract] [Full Text] [Related]

  • 23. Selectivity of McN-A-343 in stimulating phosphoinositide hydrolysis mediated by M1 muscarinic receptors.
    Hu JR, el-Fakahany EE.
    Mol Pharmacol; 1990 Dec; 38(6):895-903. PubMed ID: 1701216
    [Abstract] [Full Text] [Related]

  • 24. Cysteine pairs in the third intracellular loop of the muscarinic m1 acetylcholine receptor play a role in agonist-induced internalization.
    Sawyer GW, Ehlert FJ, Shults CA.
    J Pharmacol Exp Ther; 2008 Jan; 324(1):196-205. PubMed ID: 17540859
    [Abstract] [Full Text] [Related]

  • 25. Inhibition of acetylcholine muscarinic M(1) receptor function by the M(1)-selective ligand muscarinic toxin 7 (MT-7).
    Olianas MC, Maullu C, Adem A, Mulugeta E, Karlsson E, Onali P.
    Br J Pharmacol; 2000 Oct; 131(3):447-52. PubMed ID: 11015294
    [Abstract] [Full Text] [Related]

  • 26. Classical and atypical agonists activate M1 muscarinic acetylcholine receptors through common mechanisms.
    Randáková A, Dolejší E, Rudajev V, Zimčík P, Doležal V, El-Fakahany EE, Jakubík J.
    Pharmacol Res; 2015 Jul; 97():27-39. PubMed ID: 25882246
    [Abstract] [Full Text] [Related]

  • 27. Role of two highly conserved tyrosine residues in the m1 muscarinic receptor second transmembrane domain in ligand binding and receptor function.
    Lee SY, Zhu SZ, el-Fakahany EE.
    Recept Signal Transduct; 1996 Jul; 6(1):43-52. PubMed ID: 8933621
    [Abstract] [Full Text] [Related]

  • 28. Xanomeline: a novel muscarinic receptor agonist with functional selectivity for M1 receptors.
    Shannon HE, Bymaster FP, Calligaro DO, Greenwood B, Mitch CH, Sawyer BD, Ward JS, Wong DT, Olesen PH, Sheardown MJ, Swedberg MD, Suzdak PD, Sauerberg P.
    J Pharmacol Exp Ther; 1994 Apr; 269(1):271-81. PubMed ID: 7909557
    [Abstract] [Full Text] [Related]

  • 29. Interaction of neuromuscular blocking drugs with recombinant human m1-m5 muscarinic receptors expressed in Chinese hamster ovary cells.
    Cembala TM, Sherwin JD, Tidmarsh MD, Appadu BL, Lambert DG.
    Br J Pharmacol; 1998 Nov; 125(5):1088-94. PubMed ID: 9846649
    [Abstract] [Full Text] [Related]

  • 30. Selective coupling with K+ currents of muscarinic acetylcholine receptor subtypes in NG108-15 cells.
    Fukuda K, Higashida H, Kubo T, Maeda A, Akiba I, Bujo H, Mishina M, Numa S.
    Nature; 1988 Sep 22; 335(6188):355-8. PubMed ID: 2843772
    [Abstract] [Full Text] [Related]

  • 31. The muscarinic M1 agonist xanomeline increases soluble amyloid precursor protein release from Chinese hamster ovary-m1 cells.
    Eckols K, Bymaster FP, Mitch CH, Shannon HE, Ward JS, DeLapp NW.
    Life Sci; 1995 Sep 22; 57(12):1183-90. PubMed ID: 7674807
    [Abstract] [Full Text] [Related]

  • 32. Immediate and delayed consequences of xanomeline wash-resistant binding at the M3 muscarinic receptor.
    Noetzel MJ, Grant MK, El-Fakahany EE.
    Neurochem Res; 2009 Jun 22; 34(6):1138-49. PubMed ID: 19082883
    [Abstract] [Full Text] [Related]

  • 33. Muscarinic acetylcholine receptor antagonists inhibit chick scleral chondrocytes.
    Lind GJ, Chew SJ, Marzani D, Wallman J.
    Invest Ophthalmol Vis Sci; 1998 Nov 22; 39(12):2217-31. PubMed ID: 9804129
    [Abstract] [Full Text] [Related]

  • 34. Mechanisms of M3 muscarinic receptor regulation by wash-resistant xanomeline binding.
    Noetzel MJ, Grant MK, El-Fakahany EE.
    Pharmacology; 2009 Nov 22; 83(5):301-17. PubMed ID: 19401618
    [Abstract] [Full Text] [Related]

  • 35. Regulation of m1 muscarinic receptors and nNOS mRNA levels by autoantibodies from schizophrenic patients.
    Ganzinelli S, Borda T, Sterin-Borda L.
    Neuropharmacology; 2006 Mar 22; 50(3):362-71. PubMed ID: 16289249
    [Abstract] [Full Text] [Related]

  • 36. Pharmacological evaluation of the long-term effects of xanomeline on the M(1) muscarinic acetylcholine receptor.
    Grant MK, Noetzel MJ, De Lorme KC, Jakubík J, Doležal V, El-Fakahany EE.
    PLoS One; 2010 Dec 23; 5(12):e15722. PubMed ID: 21203415
    [Abstract] [Full Text] [Related]

  • 37. Mixed agonist-antagonist properties of clozapine at different human cloned muscarinic receptor subtypes expressed in Chinese hamster ovary cells.
    Olianas MC, Maullu C, Onali P.
    Neuropsychopharmacology; 1999 Mar 23; 20(3):263-70. PubMed ID: 10063486
    [Abstract] [Full Text] [Related]

  • 38. Nitric oxide synthase, arginase and cyclooxygenase are involved in muscarinic receptor activation in different murine mammary adenocarcinoma cell lines.
    Español A, Eiján AM, Mazzoni E, Davel L, Jasnis MA, Sacerdote De Lustig E, Sales ME.
    Int J Mol Med; 2002 Jun 23; 9(6):651-7. PubMed ID: 12011984
    [Abstract] [Full Text] [Related]

  • 39. Pharmacological assessment of m1 muscarinic acetylcholine receptor-gq/11 protein coupling in membranes prepared from postmortem human brain tissue.
    Salah-Uddin H, Thomas DR, Davies CH, Hagan JJ, Wood MD, Watson JM, Challiss RA.
    J Pharmacol Exp Ther; 2008 Jun 23; 325(3):869-74. PubMed ID: 18322150
    [Abstract] [Full Text] [Related]

  • 40. Probing the molecular mechanism of interaction between 4-n-butyl-1-[4-(2-methylphenyl)-4-oxo-1-butyl]-piperidine (AC-42) and the muscarinic M(1) receptor: direct pharmacological evidence that AC-42 is an allosteric agonist.
    Langmead CJ, Fry VA, Forbes IT, Branch CL, Christopoulos A, Wood MD, Herdon HJ.
    Mol Pharmacol; 2006 Jan 23; 69(1):236-46. PubMed ID: 16207821
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 17.